Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:52 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 169–192 of 2,449 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Implant Clear all

Conditions: Dysfunctional Right Ventricular Outflow Tract (RVOT) Conduit
Interventions: Melody® Transcatheter Pulmonary Valve; Device
Lead sponsor: Medtronic Cardiovascular; Industry
Eligibility: Not listed
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2017
U.S. locations: 10
States / cities: San Diego, California • Oak Lawn, Illinois • Ann Arbor, Michigan + 7 more

Conditions: Nasogastric Tube
Interventions: Nasogastric Tube; Device
Lead sponsor: Gravitas Medical, Inc.; Industry
Eligibility: 0 Weeks to 18 Weeks
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Overactive Bladder, Urinary Incontinence, Fecal Incontinence
Interventions: Fluoroscopy; Radiation
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years and older · Female only
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Congestive Heart Failure, Coronary Artery Disease, Myocardial Infarction
Interventions: MyoCell™ Autologous Myoblasts; Drug
Lead sponsor: Bioheart, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 5
States / cities: Fort Lauderdale, Florida • Atlanta, Georgia • Chicago, Illinois + 2 more

Conditions: Heart Failure, Circulatory Disorders Postprocedural Complication, Cardiomyopathy, Congestive, Surgery
Interventions: Not listed
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Oral Ridge Preservation
Interventions: NuOss XC; Device
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 64 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Aortic Valve Stenosis
Interventions: LOTUS Edge Valve System; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 382 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 49
States / cities: Huntsville, Alabama • Tucson, Arizona • Little Rock, Arkansas + 39 more

Conditions: Pain
Interventions: Transcutaneous Electrical Nerve Stimulation (TENS); Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: New Haven, Connecticut

Conditions: Shock
Interventions: ICD/ CRT-D; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 1,670 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Partially Edentulous Maxilla or Mandible
Interventions: PrimeTaper EV; Device
Lead sponsor: McGuire Institute; Industry
Eligibility: 25 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 8
States / cities: Aurora, Colorado • Broomfield, Colorado • Oakbrook Terrace, Illinois + 5 more

Conditions: Bleeding, Implants, Breakthrough Bleeding
Interventions: Placebo, Curcumin; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 15 Years to 45 Years · Female only
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Coronary Artery Disease
Interventions: Fortify® ST, Fortify Assura® ST, Ellipse® ST family of devices; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 2,258 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 97
States / cities: Birmingham, Alabama • Huntsville, Alabama • Mesa, Arizona + 85 more

Conditions: Radial Head Fractures
Interventions: Not listed
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 3
States / cities: Chicago, Illinois • Evanston, Illinois

Conditions: Knee Prosthesis, Knee Arthroplasty
Interventions: DePuy fixed-bearing Total Condylar III (TC3) TKA, DePuy PFC Rotating Platform TC3 TKA; Device
Lead sponsor: The University of Tennessee, Knoxville; Other
Eligibility: 40 Years to 85 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 3
States / cities: Denver, Colorado • Knoxville, Tennessee

Conditions: Metastatic Sarcoma, Recurrent Sarcoma, Resectable Sarcoma
Interventions: Doxorubicin, Doxorubicin Hydrochloride, Drug Delivery Microdevice, Everolimus, Ganitumab, Ifosfamide, Irinotecan, Pazopanib, Polyethylene Glycol, Temozolomide, Temsirolimus, Therapeutic Conventional Surgery, Vincristine; Drug · Device · Biological + 1 more
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 10 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Pain Associated With Epidural Needle Insertion
Interventions: Synera(TM), Placebo patch; Drug · Other
Lead sponsor: IWK Health Centre; Other
Eligibility: 18 Years and older · Female only
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Infertility, Female
Interventions: G-CSF, Saline; Drug
Lead sponsor: Center for Human Reproduction; Other
Eligibility: 21 Years to 45 Years · Female only
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Contraception
Interventions: Misoprostol, Placebo; Drug · Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 3 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Migraine
Interventions: Precision; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 179 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2018
U.S. locations: 15
States / cities: Denver, Colorado • Stamford, Connecticut • Augusta, Georgia + 11 more

Conditions: Pain, Postoperative
Interventions: XaraColl, Placebo; Drug · Other
Lead sponsor: Innocoll; Industry
Eligibility: 18 Years and older
Enrollment: 319 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 24
States / cities: Anniston, Alabama • Birmingham, Alabama • Anaheim, California + 19 more

Conditions: Epidural Anesthesia, Spinal Ultrasound, Obesity
Interventions: Palpation, Ultrasound; Procedure · Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years to 45 Years · Female only
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: computer-assisted intervention, medical chart review, questionnaire administration, survey administration; Other
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 120 Years
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 2
States / cities: Nashville, Tennessee

Conditions: Fractures, Bone, Fracture Multiple
Interventions: Biomet Cannulated Screw: 3.0, 4.0, 5.0, 6.5, and 8.0mm screws.; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 3
States / cities: Warsaw, Indiana • Worthington, Ohio • Lake Ridge, Virginia

Conditions: Ischemic Stroke
Interventions: Active Sphenopalatine Ganglion (SPG) Stimulation, Sham Sphenopalatine Ganglion (SPG) Stimulation; Device
Lead sponsor: BrainsGate; Industry
Eligibility: 40 Years to 85 Years
Enrollment: 1,078 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 7
States / cities: Sarasota, Florida • Winfield, Illinois • Greensboro, North Carolina + 3 more

Search by objective public record fields.

Melody® Transcatheter Pulmonary Valve Post-Approval Study

Gravitas Feeding Tube System Placement in Neonates

Percutaneous Nerve Evaluation With Fluoroscopy Versus Without

Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection

Observational Hemodynamic Monitoring During LVAD Implantation Among Individuals With Advanced Heart Failure

Histologic Evaluation of Healing Following Tooth Extraction With Ridge Preservation Using NuOss XC and NuOss Particulate

REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects

Transcutaneous Electrical Nerve Stimulation (TENS) for Intrauterine Device (IUD) Insertion Pain

Programming Implantable Cardioverter Defibrillators in Patients With Primary Prevention Indication

Non-Guided vs. Guided Surgery to Immediately Loaded PrimeTaper Implants in Partially Edentulous Patients

Use of Curcumin to Treat Unfavorable Bleeding Patterns in Contraceptive Implant Users

ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients

Comparison of Two Radial Head Implants

Comparison of Kinematics for Subjects Implanted With a PFC Sigma Rotating Platform or Fixed Bearing TC3 Prosthesis

Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

Synera™ for Epidural Needle Insertion

Effect of Colony Stimulating Factor on Poor Endometrial Development During IVF

Intra Uterine Device Insertion in Nulliparous Women

Treatment for Migraines With an Implantable Device

Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty

Utility of Ultrasound in Identification of Midline and Placement of Epidural in Severely Obese Parturients

Satisfaction With Placement of Implantable Venous Access Devices in Patients With Solid Tumors

MDR - Biomet Cannulated Screws

Implant for Augmentation of Cerebral Blood Flow Trial, Effectiveness and Safety in a 24 Hour Window